Grace Therapeutics, Inc. (GRCE)

Grace Therapeutics Statistics

Total Valuation

GRCE has a market cap or net worth of $48.59 million. The enterprise value is $29.87 million.

Market Cap	48.59M
Enterprise Value	29.87M

Important Dates

The last earnings date was Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

GRCE has 15.47 million shares outstanding. The number of shares has increased by 23.94% in one year.

Current Share Class	15.47M
Shares Outstanding	15.47M
Shares Change (YoY)	+23.94%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	19.28%
Owned by Institutions (%)	10.51%
Float	9.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.67
P/TBV Ratio	3.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.89

Current Ratio	13.89
Quick Ratio	13.56
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -13.15% and return on invested capital (ROIC) is -13.14%.

Return on Equity (ROE)	-13.15%
Return on Assets (ROA)	-11.85%
Return on Invested Capital (ROIC)	-13.14%
Return on Capital Employed (ROCE)	-19.14%
Revenue Per Employee	n/a
Profits Per Employee	-$1.30M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.62M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.93% in the last 52 weeks. The beta is 0.60, so GRCE's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	-1.93%
50-Day Moving Average	3.08
200-Day Moving Average	2.92
Relative Strength Index (RSI)	48.26
Average Volume (20 Days)	52,625

Short Selling Information

The latest short interest is 22,196, so 0.14% of the outstanding shares have been sold short.

Short Interest	22,196
Short Previous Month	23,235
Short % of Shares Out	0.14%
Short % of Float	0.24%
Short Ratio (days to cover)	0.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.50M
Pretax Income	-9.44M
Net Income	-7.82M
EBITDA	-12.50M
EBIT	-12.50M
Earnings Per Share (EPS)	-$0.55

Balance Sheet

The company has $16.86 million in cash and n/a in debt, giving a net cash position of $16.86 million or $1.09 per share.

Cash & Cash Equivalents	16.86M
Total Debt	n/a
Net Cash	16.86M
Net Cash Per Share	$1.09
Equity (Book Value)	62.82M
Book Value Per Share	4.45
Working Capital	16.05M

Cash Flow

Operating Cash Flow	-12.01M
Capital Expenditures	n/a
Free Cash Flow	-12.01M
FCF Per Share	-$0.78

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GRCE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.94%
Shareholder Yield	-23.94%
Earnings Yield	-16.73%
FCF Yield	-25.71%

Analyst Forecast

The average price target for GRCE is $12.00, which is 282.17% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.00
Price Target Difference	282.17%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 10, 2023. It was a reverse split with a ratio of 1:6.

Last Split Date	Jul 10, 2023
Split Type	Reverse
Split Ratio	1:6

Scores

Altman Z-Score	n/a
Piotroski F-Score	1